TrialInternational journal of chronic obstructive pulmonary disease2014

Efficacy and safety of coadministration of once-daily indacaterol and glycopyrronium versus indacaterol alone in COPD patients: the GLOW6 study.

Walter Vincken et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.